These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7418184

  • 1. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
    Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP.
    Circulation; 1980 Nov; 62(5):996-1010. PubMed ID: 7418184
    [No Abstract] [Full Text] [Related]

  • 2. Verapamil in cardiac arrhythmias: an overview.
    Vohra J.
    Clin Exp Pharmacol Physiol Suppl; 1982 Nov; 6():129-34. PubMed ID: 6749351
    [Abstract] [Full Text] [Related]

  • 3. Supraventricular tachycardias.
    Wu D.
    JAMA; 1983 Jun 24; 249(24):3357-60. PubMed ID: 6854872
    [No Abstract] [Full Text] [Related]

  • 4. Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.
    Rabkin SW, Tomlinson C, Corbett BN, Cuddy TE.
    Can Med Assoc J; 1980 Jan 12; 122(1):64-8. PubMed ID: 7363198
    [No Abstract] [Full Text] [Related]

  • 5. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK, Singh BN, Roche AH, Norris RM, Mercer CJ.
    Am Heart J; 1975 Oct 12; 90(4):487-98. PubMed ID: 1163442
    [Abstract] [Full Text] [Related]

  • 6. General aspects of anti-arrhythmic treatment with aprindine.
    Kesteloot H.
    Acta Cardiol; 1974 Oct 12; Suppl 18():303-16. PubMed ID: 4138773
    [No Abstract] [Full Text] [Related]

  • 7. Management of arrhythmias with "calcium antagonists".
    Zipes DP, Gilmour RF.
    Angiology; 1982 Aug 12; 33(8):540-54. PubMed ID: 6287890
    [No Abstract] [Full Text] [Related]

  • 8. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM.
    Minerva Med; 1975 May 26; 66(39):1914-22. PubMed ID: 236526
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
    Hiejima K, Suzuki F, Takahashi M, Satake S.
    Jpn Circ J; 1983 Jan 26; 47(1):98-104. PubMed ID: 6827776
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 11. The clinical use of intravenous verapamil.
    Schamroth L.
    Am Heart J; 1980 Dec 01; 100(6 Pt 2):1070-5. PubMed ID: 7004158
    [Abstract] [Full Text] [Related]

  • 12. Dissimilar atrial rhythms in a patient with the Wolff-Parkinson-White syndrome.
    Genetos BC, Gaum WE, Etharrar V, Zipes DP.
    Chest; 1977 Nov 01; 72(5):663-6. PubMed ID: 913153
    [Abstract] [Full Text] [Related]

  • 13. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A, Peter T, Platt M, Mandel WJ.
    Am Heart J; 1981 May 01; 101(5):600-12. PubMed ID: 7223599
    [Abstract] [Full Text] [Related]

  • 14. [Demonstration of a major preexcitation syndrome during treatment of auricular flutter using intravenous injection of verapamil].
    Chaudron JM, Lebacq E.
    Acta Cardiol; 1975 May 01; 30(2):137-50. PubMed ID: 1079999
    [Abstract] [Full Text] [Related]

  • 15. Refractory supraventricular tachycardias.
    Ticzon AR, Whalen RW.
    Circulation; 1973 Mar 01; 47(3):642-53. PubMed ID: 4571059
    [No Abstract] [Full Text] [Related]

  • 16. Clinical experience with verapamil.
    Vohra J, Hunt D, Sloman G.
    Med J Aust; 1975 Sep 13; 2(11):417-21. PubMed ID: 1186549
    [Abstract] [Full Text] [Related]

  • 17. Selection of patients with recurrence of ventricular tachyarrhythmias for electrical studies.
    Horowitz LN, Spielman SR, Greenspan AM, Webb CR.
    Pacing Clin Electrophysiol; 1984 May 13; 7(3 Pt 2):499-504. PubMed ID: 6204307
    [Abstract] [Full Text] [Related]

  • 18. [Re-evaluation of the use of verapamil in supraventricular tachyarrhythmias].
    Carvalho MA, Osterne EC, Bezerra FA, Carvalho PR, Barros RB, Carneiro RD.
    Arq Bras Cardiol; 1978 Feb 13; 31 Suppl 1():83-6. PubMed ID: 678167
    [No Abstract] [Full Text] [Related]

  • 19. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ, Lie KI, Bär FW, Wesdorp JC, Dohmen HJ, Düren DR, Durrer D.
    Am J Cardiol; 1976 Aug 13; 38(2):189-94. PubMed ID: 952262
    [Abstract] [Full Text] [Related]

  • 20. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
    Strasberg B, Sagie A, Rechavia E, Katz A, Ovsyscher IA, Sclarovsky S, Agmon J.
    Cardiovasc Drugs Ther; 1989 Jan 13; 2(6):801-6. PubMed ID: 2488095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.